There were 175 press releases posted in the last 24 hours and 399,833 in the last 365 days.

CHF Solutions, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

EDEN PRAIRIE, Minn., June 06, 2017 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS), today announced that on May 25, 2017, the independent directors approved two equity awards under CHF Solution’s New-Hire Equity Incentive Plan, as material inducements to two individuals entering into employment with the Company.  The equity awards were approved in accordance with NASDAQ Listing Rule 5635(c)(4), which also requires a public announcement of equity awards that are not made under a stockholder approved equity plan.

In connection with entering into employment with CHF Solutions, Jim Breidenstein and Gordon Weber, who were not previously employees or directors of CHF Solutions, received options to purchase 339,145 and 226,097 shares, respectively, of the Company’s common stock. The option awards have an exercise price of $0.57 per share, the closing price of CHF Solution’s common stock on June 2, 2017, the date of the grant.  The options have ten-year terms and vest over a period of four years, with 25% vesting one year after the date of grant and the remaining 75% vesting in 36 approximately equal monthly increments, provided the new hire’s employment is continuing on each such date, and subject to acceleration or forfeiture upon the occurrence of certain events as set forth in the new hire’s option agreement.

About CHF Solutions

CHF Solutions, Inc. (Nasdaq:CHFS) is an early-stage medical device company focused on commercializing the Aquadex FlexFlow® System. The company’s commercial product, the Aquadex system, is indicated for temporary (up to eight hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended (longer than 8 hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization. The company’s objective is to improve the quality of life for patients with heart failure and related conditions. CHF Solutions is a Delaware corporation headquartered in Minneapolis with wholly owned subsidiaries in Australia and Ireland. The company has been listed on the NASDAQ Capital Market since February 2012.

For further information, please contact:

Claudia Drayton 	
Chief Financial Officer   
CHF Solutions, Inc. 	
T: +1-952-345-4205


Bret Shapiro
Managing Partner
516 222 2560

Investor Relations
CHF Solutions, Inc.

Primary Logo